PEG [Pegalated]

Please select from the menu above

Anecdotal observations by John Thomas

Return to Glossary
Go to Programs & Protocols
Special Insights Archive
Go to Home Page

PEG [pegalated]:  addition of polyethyleneglycol to food or to a drug formulation.

Overview

In order to protect fragile mRNA strands while being inserted into our DNA, active components are coated with PEGylated lipid nanoparticles.  The coating hides errant mRNA from the innate immune system that ordinarily would KILL/DESTROY foreign material injected into the body.

PEGylated nanoparticles have been used in several different drugs for years. Because of their effect on immune system response, people will and are experiencing OVERREACTIONS such as allergy and autoimmune dis-eases and damage liver function.

More…

Polyethylene glycol (PEG) -coated nanoparticles in the mRNA vaccines create a whole new scenario of allergy and autoimmune reactions and anaphylaxis in vulnerable recipients.  FDA now acknowledges that PEG is the probable culprit in the anaphylactic reactions associated with mRNA vaccines.

The mRNA vaccines are experimental drugs with potential for harm following vaccination and TOTALLY UNKNOWN LONG TERM effects.  Avoid them where possible and prepare with Plan-B for when you cannot, such as emergency room visits following crisis.

mRNA: in molecular biology, messenger RNA (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome for synthesizing a protein.  An acronym that stands for messenger ribonucleic acid.

mRNA is a protein made in the nucleus of cells and a messenger for transfer of DNA instructions into the cytoplasm [fluid within the cell membrane, but outside of the nucleus.]

The synthetic mRNA molecule is vulnerable to destruction, both by temperature [must not be allowed to rise above -71F] and by the body’s innate immune system.

Suggestions

  1. Change your lifestyle and your diet.
  2. Embrace Young Again Club Protocols.
  3. Ask for guidance and be open to new ideas.

Return to Glossary
Go to Programs & Protocols
Special Insights Archive
Go to Home Page